BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10512067)

  • 21. [Compound A: toxicology and clinical relevance].
    Kharasch ED
    Anaesthesist; 1998 Nov; 47 Suppl 1():S7-10. PubMed ID: 9893874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recovery and kinetic characteristics of desflurane and sevoflurane in volunteers after 8-h exposure, including kinetics of degradation products.
    Eger EI; Bowland T; Ionescu P; Laster MJ; Fang Z; Gong D; Sonner J; Weiskopf RB
    Anesthesiology; 1997 Sep; 87(3):517-26. PubMed ID: 9316955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mass-spectrometric control of compound A during minimal flow anesthesia and its influence on liver and kidneys functions].
    Faizov II; Levshankov AI; Shchegolev AV; Elizarov AIu
    Anesteziol Reanimatol; 2013; (4):14-8. PubMed ID: 24341036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dehydration of Baralyme increases compound A resulting from sevoflurane degradation in a standard anesthetic circuit used to anesthetize swine.
    Steffey EP; Laster MJ; Ionescu P; Eger EI; Gong D; Weiskopf RB
    Anesth Analg; 1997 Dec; 85(6):1382-6. PubMed ID: 9390613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sevoflurane is epileptogenic in healthy subjects at surgical levels of anesthesia.
    Jäntti VH; Sonkajärvi E
    Neurology; 2004 Jun; 62(12):2335; author reply 2335. PubMed ID: 15210918
    [No Abstract]   [Full Text] [Related]  

  • 26. Sofnolime with different water content causes different effects in two sevoflurane inhalational induction techniques with respect to the output of compound-A.
    Liu SJ; Li Y; Sun B; Wang CS; Gong YL; Zhou YM; Li EY
    Int J Med Sci; 2012; 9(6):435-40. PubMed ID: 22859903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compound A concentrations during sevoflurane anesthesia in children depend on fresh gas flow.
    Aldrete JA
    Anesthesiology; 1996 Sep; 85(3):684. PubMed ID: 8853102
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma inorganic fluoride and intracircuit degradation product concentrations in long-duration, low-flow sevoflurane anesthesia.
    Bito H; Ikeda K
    Anesth Analg; 1994 Nov; 79(5):946-51. PubMed ID: 7978414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacovigilance and safety aspects of sevoflurane.
    Kharasch ED
    Acta Anaesthesiol Scand Suppl; 1997; 111():146-8. PubMed ID: 9420990
    [No Abstract]   [Full Text] [Related]  

  • 30. Low-flow sevoflurane compared with low-flow isoflurane anesthesia in patients with stable renal insufficiency.
    Conzen PF; Kharasch ED; Czerner SF; Artru AA; Reichle FM; Michalowski P; Rooke GA; Weiss BM; Ebert TJ
    Anesthesiology; 2002 Sep; 97(3):578-84. PubMed ID: 12218523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrotoxicity of halogenated inhalational anaesthetics: fictions and facts.
    Reichle FM; Conzen PF; Peter K
    Eur Surg Res; 2002; 34(1-2):188-95. PubMed ID: 11867922
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of plasma alpha glutathione S-transferase concentrations during and after low-flow sevoflurane or isoflurane anaesthesia.
    Higuchi H; Adachi Y; Wada H; Kanno M; Satoh T
    Acta Anaesthesiol Scand; 2001 Nov; 45(10):1226-9. PubMed ID: 11736674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Open-label Comparison of a New Generic Sevoflurane Formulation With Original Sevoflurane in Patients Scheduled for Elective Surgery Under General Anesthesia.
    Byon HJ; Choi BM; Bang JY; Lee EK; Lee SS; Noh GJ
    Clin Ther; 2015 Apr; 37(4):887-901. PubMed ID: 25697421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postoperative seizure-like activity following sevoflurane anesthesia.
    Terasako K; Ishii S
    Acta Anaesthesiol Scand; 1996 Sep; 40(8 Pt 1):953-4. PubMed ID: 8908234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative differences in the production and toxicity of CF2=BrCl versus CH2F-O-C(=CF2)(CF3) (compound A): the safety of halothane does not indicate the safety of sevoflurane.
    Eger EI; Ionescu P; Laster MJ; Gong D; Weiskopf RB; Kerschmann RL
    Anesth Analg; 1997 Nov; 85(5):1164-70. PubMed ID: 9356119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the water content of soda lime on compound A concentration in the anesthesia circuit in sevoflurane anesthesia.
    Bito H; Ikeuchi Y; Ikeda K
    Anesthesiology; 1998 Jan; 88(1):66-71. PubMed ID: 9447857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compound A concentrations during sevoflurane anesthesia in children.
    Frink EJ; Green WB; Brown EA; Malcomson M; Hammond LC; Valencia FG; Brown BR
    Anesthesiology; 1996 Mar; 84(3):566-71. PubMed ID: 8659785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of Amsorb, sodalime, and Baralyme degradation of volatile anesthetics and formation of carbon monoxide and compound a in swine in vivo.
    Kharasch ED; Powers KM; Artru AA
    Anesthesiology; 2002 Jan; 96(1):173-82. PubMed ID: 11753018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Baralyme dehydration increases and soda lime dehydration decreases the concentration of compound A resulting from sevoflurane degradation in a standard anesthetic circuit.
    Eger EI; Ionescu P; Laster MJ; Weiskopf RB
    Anesth Analg; 1997 Oct; 85(4):892-8. PubMed ID: 9322476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of xenon on hemodynamic responses to skin incision in humans.
    Nakata Y; Goto T; Morita S
    Anesthesiology; 1999 Feb; 90(2):406-10. PubMed ID: 9952145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.